CUZZOLIN, ALBERTO
 Distribuzione geografica
Continente #
NA - Nord America 1.286
EU - Europa 183
AS - Asia 182
AF - Africa 2
Continente sconosciuto - Info sul continente non disponibili 2
SA - Sud America 2
Totale 1.657
Nazione #
US - Stati Uniti d'America 1.282
CN - Cina 100
SG - Singapore 57
IT - Italia 53
FI - Finlandia 29
GB - Regno Unito 19
DE - Germania 18
FR - Francia 17
IN - India 17
RU - Federazione Russa 15
SE - Svezia 13
IE - Irlanda 6
CA - Canada 4
HK - Hong Kong 4
NL - Olanda 3
UA - Ucraina 3
AT - Austria 2
BR - Brasile 2
SS - ???statistics.table.value.countryCode.SS??? 2
BE - Belgio 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
ID - Indonesia 1
JP - Giappone 1
KR - Corea 1
MM - Myanmar 1
NG - Nigeria 1
NO - Norvegia 1
SI - Slovenia 1
ZA - Sudafrica 1
Totale 1.657
Città #
Fairfield 237
Woodbridge 131
Ann Arbor 93
Houston 92
Ashburn 87
Cambridge 80
Seattle 79
Chandler 78
Wilmington 64
Santa Clara 56
Singapore 43
Padova 28
Boardman 24
Beijing 22
San Diego 22
Des Moines 21
Helsinki 21
Medford 16
Princeton 16
Pune 12
Los Angeles 10
Nanjing 10
Columbus 9
Jacksonville 9
Cagliari 6
Dublin 6
Falls Church 6
Hebei 5
Guangzhou 4
Hong Kong 4
Shanghai 4
Dallas 3
London 3
North York 3
Shenyang 3
Tianjin 3
Jiaxing 2
Jinan 2
Juba 2
Milan 2
Nanchang 2
Roxbury 2
São Paulo 2
Wuhan 2
Bochum 1
Changsha 1
Chiswick 1
Denver 1
Florence 1
Groningen 1
Hangzhou 1
Hounslow 1
Incheon 1
Jakarta 1
Kharkiv 1
Kumar 1
Kunming 1
Kunshan 1
Lanzhou 1
Leawood 1
Manchester 1
Monmouth Junction 1
New Albany 1
New Bedfont 1
New York 1
Nuremberg 1
Quanzhou 1
Redwood City 1
Suyicun 1
Taizhou 1
Tappahannock 1
Vancouver 1
Wenxin 1
Zhengzhou 1
Zurich 1
Totale 1.357
Nome #
DockBench: An Integrated Informatic Platform Bridging the Gap between the Robust Validation of Docking Protocols and Virtual Screening Simulations 180
ALK Kinase Domain Mutations in Primary Anaplastic Large Cell Lymphoma: Consequences on NPM-ALK Activity and Sensitivity to Tyrosine Kinase Inhibitors. 175
Deciphering the Complexity of Ligand-Protein Recognition Pathways Using Supervised Molecular Dynamics (SuMD) Simulations 155
Exploring Protein-Peptide Recognition Pathways Using a Supervised Molecular Dynamics Approach 141
AquaMMapS: an alternative tool to monitor the role of water molecules during protein-ligand association 132
Understanding allosteric interactions in G protein-coupled receptors using Supervised Molecular Dynamics: A prototype study analysing the human A3 adenosine receptor positive allosteric modulator LUF6000 122
New Trends in Inspecting GPCR-ligand Recognition Process: the Contribution of the Molecular Modeling Section (MMS) at the University of Padova 119
DockBench as docking selector tool: the lesson learned from D3R Grand Challenge 2015 111
Can We Still Trust Docking Results? An Extension of the Applicability of DockBench on PDBbind Database 102
Combining self- and cross-docking as benchmark tools: the performance of DockBench in the D3R Grand Challenge 2 93
Synthesis and preliminary structure-activity relationship study of 2-aryl-2H-pyrazolo[4,3-c]quinolin-3-ones as potential checkpoint kinase 1 (Chk1) inhibitors 82
A deep-learning approach toward rational molecular docking protocol selection 75
Novel in silico approaches to depict the protein-ligand recognition events 61
Computationally driven discovery of SARS-CoV-2 Mpro inhibitors: from design to experimental validation 56
Alternative quality assessment strategy to compare performances of GPCR-ligand docking protocols: the human adenosine A(2A) receptor as a case study. 45
Exploring the recognition pathway at the human A2A adenosine receptor of the endogenous agonist adenosine using supervised molecular dynamics simulations 32
Totale 1.681
Categoria #
all - tutte 6.867
article - articoli 6.578
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.445


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020141 0 0 0 0 0 0 25 30 41 23 14 8
2020/2021281 8 12 17 8 5 6 0 25 33 103 55 9
2021/2022263 6 46 19 21 31 11 12 41 10 6 17 43
2022/2023192 28 7 4 31 29 29 6 12 26 5 11 4
2023/2024179 19 19 22 8 29 18 9 11 5 10 12 17
2024/2025191 0 34 21 19 83 23 11 0 0 0 0 0
Totale 1.681